In this study, we have shown that the combination of immune checkpoint blockade with PLGA particle vaccine containing TLR3/RIG-I ligand Riboxxim and tumor antigen shows a synergistic efficacy in suppression of tumor growth (Fig. 6). The gene discussed is TLR3; the disease is neoplasm.